Prostatis Group’s State Street SPDR S&P Aerospace & Defense ETF XAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Sell
13,516
-4,861
-26% -$1.33M 0.88% 38
2025
Q4
$4.43M Buy
18,377
+6,728
+58% +$1.6M 1.06% 25
2025
Q3
$2.74M Sell
11,649
-11,407
-49% -$2.49M 0.69% 41
2025
Q2
$4.86M Buy
+23,056
New +$4.18M 1.39% 18

Other funds holding XAR

Prostatis Group's XAR Position: Q1 2026 in Review

Prostatis Group reduced its State Street SPDR S&P Aerospace & Defense ETF (XAR) stake by 26% in Q1 2026, selling an estimated $1.33M and leaving 13,516 shares worth $3.43M. The position accounts for 0.88% of the portfolio, ranked #38.

Prostatis Group first reported a position in XAR in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.86M in Q2 2025. 566 funds tracked by Wall St. Rank hold XAR as of Q1 2026.

  • Prostatis Group held 13,516 shares of State Street SPDR S&P Aerospace & Defense ETF worth $3.43M as of Q1 2026.
  • Prostatis Group sold 4,861 State Street SPDR S&P Aerospace & Defense ETF shares in Q1 2026, an estimated $1.33M.
  • State Street SPDR S&P Aerospace & Defense ETF made up 0.88% of Prostatis Group's portfolio in Q1 2026, its #38 holding.
  • Prostatis Group first reported a position in State Street SPDR S&P Aerospace & Defense ETF in Q2 2025 and has held it in 4 quarters since.
  • Prostatis Group's State Street SPDR S&P Aerospace & Defense ETF position peaked at $4.86M in Q2 2025.
  • 566 funds tracked by Wall St. Rank held State Street SPDR S&P Aerospace & Defense ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.